ASP7991

DRUG4 trials

Sponsors

Astellas Pharma Inc

Conditions

HealthyPatients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis TherapyPharmacodynamics of ASP7991Pharmacokinetics of ASP7991Secondary Hyperparathyroidism

Phase 1

A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers

CompletedNCT01675518

Astellas Pharma IncHealthy, Pharmacokinetics of ASP7991

Start: 2012-01-31End: 2012-06-30Updated: 2012-08-30

Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects

CompletedNCT01872013

Astellas Pharma IncHealthy, Pharmacokinetics of ASP7991

Start: 2012-11-30End: 2013-02-28Updated: 2013-06-07

Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis

CompletedNCT01872026

Astellas Pharma IncPatients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy, Pharmacodynamics of ASP7991, Pharmacokinetics of ASP7991

Start: 2012-12-26End: 2013-06-26Updated: 2024-11-06

Phase 2

A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

CompletedNCT02133404

Astellas Pharma IncSecondary Hyperparathyroidism

Start: 2014-03-14End: 2014-11-10Updated: 2024-11-06